BRAF and cutaneous squamous cell carcinoma: Other side effects of BRAF inhibition include conditions with hyperproliferation of keratinocytes leading to the development of a spectrum of hyperkeratotic conditions including actinic keratosis, Grover’s disease, cutaneous squamous cell carcinoma and acneiform eruptions.